Chemical Structure (Cabergoline Tablets 1)
Cabergoline Tablet
Product Images NDC 69238-2693
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cabergoline (NDC 69238-2693). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Label (Cabergoline Tablets 2)
This is a description of Cabergoline tablets containing 0.5 mg of Cabergoline USP. The usual dosage information can be found in the package insert. The tablets should be stored at temperatures between 15°C to 30°C. It is a prescription-only medication and should be kept out of reach of children. The tablets are distributed by Amneal Pharmaceuticals LLC and manufactured by Ritsa Pharma Private Limited in Hyderabad, India.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
